» Articles » PMID: 20622364

Daily Online Localization Using Implanted Fiducial Markers and Its Impact on Planning Target Volume for Carcinoma Prostate

Overview
Specialty Oncology
Date 2010 Jul 13
PMID 20622364
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Aim of the study was to assess prostate motion on daily basis with respect to setup and to compare the shifts based on bony anatomy and gold fiducial markers.

Materials And Methods: Gold fiducial markers were inserted in prostate under U/S guidance and daily portal images were taken and compared with digitally reconstructed images, both using bony landmarks and fiducial markers as reference. A dose of 2 MU was given for two orthogonal images daily. The mean and standard deviation of displacement using gold seeds and bone were calculated. Systematic and random errors were generated. The planning target volume (PTV) was calculated using the Van Herk formula.

Results: A total of 180 portal images from 10 patients were studied. The mean displacement along x, y and z axes was 1.67 mm, 3.58 mm, and 1.76 mm using fiducial markers and 2.12 mm, 3.47 mm, and 2.09 mm using bony landmarks, respectively. The mean internal organ motion was 1.23 mm (+1.45), 3.11 mm (+2.69 mm); and 1.87 mm (+1.67 mm) along x, y and z axes, respectively. The PTV to account for prostate motion if daily matching was not done was 4.64 mm, 10.41 mm and 4.40 mm along lateral, superoinferior, and anteroposterior directions, respectively. If bony landmarks were used for daily matching, margins of 3.61 mm, 7.31 mm, and 4.72 mm in lateral, superoinferior, and anteroposterior directions should be added to the clinical target volume.

Conclusion: Daily alignment using gold fiducial markers is an effective method of localizing prostate displacement. It provides the option of reducing margins, thus limiting normal tissue toxicity and allowing the possibility of dose escalation for better long-term control.

Citing Articles

Positioning error and expanding margins of planning target volume with kilovoltage cone beam computed tomography for prostate cancer radiotherapy.

Wang G, Wang W, Liu Y, Dong H, Hu Y Onco Targets Ther. 2018; 11:1981-1988.

PMID: 29670373 PMC: 5898597. DOI: 10.2147/OTT.S152915.


Qualitative evaluation of fiducial markers for radiotherapy imaging.

Chan M, Cohen G, Deasy J Technol Cancer Res Treat. 2014; 14(3):298-304.

PMID: 25230715 PMC: 4786024. DOI: 10.1177/1533034614547447.


Assessment of interfractional prostate motion in patients immobilized in the prone position using a thermoplastic shell.

Ikeda I, Mizowaki T, Sawada Y, Nakata M, Norihisa Y, Ogura M J Radiat Res. 2013; 55(1):168-74.

PMID: 23860549 PMC: 3885122. DOI: 10.1093/jrr/rrt089.


Prostate rotation detected from implanted markers can affect dose coverage and cannot be simply dismissed.

Shang Q, Sheplan Olsen L, Stephans K, Tendulkar R, Xia P J Appl Clin Med Phys. 2013; 14(3):4262.

PMID: 23652257 PMC: 5714427. DOI: 10.1120/jacmp.v14i3.4262.


Determination of optimal fiducial marker across image-guided radiation therapy (IGRT) modalities: visibility and artifact analysis of gold, carbon, and polymer fiducial markers.

Handsfield L, Yue N, Zhou J, Chen T, Goyal S J Appl Clin Med Phys. 2012; 13(5):3976.

PMID: 22955665 PMC: 5718239. DOI: 10.1120/jacmp.v13i5.3976.